HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -5.05M | -4.69M | -4.52M | -5.89M | -6.50M |
| Total Depreciation and Amortization | 86.10K | 100.00K | 133.80K | 167.80K | 185.50K |
| Total Amortization of Deferred Charges | 71.80K | 84.00K | 101.50K | 109.60K | 117.70K |
| Total Other Non-Cash Items | 712.10K | 1.30M | 185.20K | 429.20K | 419.40K |
| Change in Net Operating Assets | -178.80K | 1.19M | -499.90K | -667.90K | -164.60K |
| Cash from Operations | -4.36M | -2.02M | -4.60M | -5.85M | -5.94M |
| Capital Expenditure | -6.20K | 0.00 | -12.00K | -2.70K | -8.40K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 104.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.54M | 3.30M | 5.05M | -1.41M | 5.40M |
| Cash from Investing | -3.54M | 3.30M | 5.14M | -1.41M | 5.39M |
| Total Debt Issued | -- | 0.00 | 822.90K | -- | -- |
| Total Debt Repaid | -812.70K | -1.27M | -3.75M | -1.34M | -1.42M |
| Issuance of Common Stock | -- | 9.07M | -- | -- | 7.61M |
| Repurchase of Common Stock | -200.00 | -400.00 | -40.70K | -509.70K | -8.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -497.20K | -100.40K | -112.80K | 270.70K | -611.10K |
| Cash from Financing | -1.31M | 7.70M | -3.08M | -1.58M | 5.57M |
| Foreign Exchange rate Adjustments | 3.90K | 21.40K | -13.10K | -11.00K | -3.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.21M | 9.00M | -2.54M | -8.86M | 5.01M |
